Logo image
Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine
Journal article   Peer reviewed

Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine

Bram Slütter, Lecia L Pewe, Peter Lauer and John T Harty
The Journal of immunology (1950), Vol.190(8), pp.3854-3858
04/15/2013
DOI: 10.4049/jimmunol.1202790
PMCID: PMC3622175
PMID: 23467935

View Online

Abstract

Memory CD8 T cells recognizing conserved proteins from influenza A virus (IAV), such as nucleoprotein, have the potential to provide protection in individuals who lack the proper neutralizing Abs. In this study, we show that the most potent CD8 T cell-inducing influenza vaccine on the market (Flumist) does not induce sufficient numbers of cross-reactive CD8 T cells to provide substantial protection against lethal nonhomologous IAV challenge. However, Flumist-primed CD8 T cells rapidly acquire memory characteristics and can respond to short-interval boosting to greatly enlarge the IAV-specific memory pool, which is sufficient to protect mice from nonhomologous IAV challenge. Thus, a current vaccine strategy, Flumist, may serve as a priming platform for the rapid induction of large numbers of memory CD8 T cells with the capacity for broad protection against influenza.
Influenza Vaccines - administration & dosage Humans Cross Reactions - immunology Lymphocyte Activation - immunology Animals Influenza Vaccines - immunology Time Factors CD8-Positive T-Lymphocytes - virology CD8-Positive T-Lymphocytes - metabolism Influenza Vaccines - therapeutic use Female Immunologic Memory Influenza A virus - immunology Influenza, Human - virology Mice Mice, Inbred BALB C CD8-Positive T-Lymphocytes - immunology Influenza, Human - prevention & control Influenza, Human - immunology

Details

Metrics

Logo image